Erythropoietin mediates re-programming of endotoxin-tolerant macrophages through PI3K/AKT signaling and protects mice against secondary infection

Initial lipopolysaccharide (LPS) exposure leads to a hypo-responsive state by macrophages to a secondary stimulation of LPS, known as endotoxin tolerance. However, recent findings show that functions of endotoxin-tolerant macrophages are not completely suppressed, whereas they undergo a functional re-programming process with upregulation of a panel of molecules leading to enhanced protective functions including antimicrobial and tissue-remodeling activities. However, the underlying molecular mechanisms are still elusive. Erythropoietin (EPO), a glycoprotein regulated by hypoxia-inducible factor 1α (HIF-1α), exerts anti-inflammatory and tissue-protective activities. Nevertheless, the potential effects of EPO on functional re-programming of endotoxin-tolerant macrophages have not been investigated yet. Here, we found that initial LPS exposure led to upregulation of HIF-1α/EPO in macrophages and that EPO enhanced tolerance in tolerized macrophages and mice as demonstrated by suppressed proinflammatory genes such as Il1b, Il6, and Tnfa after secondary LPS stimulation. Moreover, we showed that EPO improved host protective genes in endotoxin-tolerant macrophages and mice, such as the anti-bacterial genes coding for cathelicidin-related antimicrobial peptide (Cnlp) and macrophage receptor with collagenous structure (Marco), and the tissue-repairing gene vascular endothelial growth factor C (Vegfc). Therefore, our findings indicate that EPO mediates the functional re-programming of endotoxin-tolerant macrophages. Mechanistically, we found that PI3K/AKT signaling contributed to EPO-mediated re-programming through upregulation of Irak3 and Wdr5 expression. Specifically, IL-1 receptor-associated kinase 3 (IRAK3) was responsible for inhibiting proinflammatory genes Il1b, Il6, and Tnfa in tolerized macrophages after LPS rechallenge, whereas WDR5 contributed to the upregulation of host beneficial genes including Cnlp, Marco, and Vegfc. In a septic model of mice, EPO pretreatment significantly promoted endotoxin-tolerant re-programming, alleviated lung injury, enhanced bacterial clearance, and decreased mortality in LPS-tolerized mice after secondary infection of Escherichia coli. Collectively, our results reveal a novel role for EPO in mediating functional re-programming of endotoxin-tolerant macrophages; thus, targeting EPO appears to be a new therapeutic option in sepsis and other inflammatory disorders.

[1]  X. Wang,et al.  Multiple mechanisms of salidroside on anti-tumor effects. , 2021, European review for medical and pharmacological sciences.

[2]  Fengxue Zhang,et al.  Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections , 2021, Frontiers in Immunology.

[3]  Yu Zheng,et al.  Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties. , 2021, Chemico-biological interactions.

[4]  Qun Xia,et al.  Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment. , 2020, European journal of pharmacology.

[5]  W. Ju,et al.  Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway , 2020, Aging.

[6]  M. Singer,et al.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads , 2020, EMBO molecular medicine.

[7]  X. Ju,et al.  Advances in Research on Anticancer Properties of Salidroside , 2020, Chinese Journal of Integrative Medicine.

[8]  Hong Shi,et al.  Anti-inflammatory effects of Rhodiola rosea L.: A review. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  X. Fang,et al.  Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  N. Kissoon,et al.  The global burden of sepsis: barriers and potential solutions , 2018, Critical Care.

[11]  A. Perkins,et al.  EPO does not promote interaction between the erythropoietin and beta-common receptors , 2018, Scientific Reports.

[12]  Lin Qiu,et al.  PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407 , 2017, Cell Death & Disease.

[13]  T. Hawn,et al.  MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage , 2016, Genes and Immunity.

[14]  C. Thiemermann,et al.  Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. , 2015, Pharmacology & therapeutics.

[15]  V. Nizet,et al.  Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. , 2015, Immunity.

[16]  B. Wei,et al.  Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. , 2014, Immunity.

[17]  R. Bellomo,et al.  Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. , 2014, JAMA.

[18]  J. Marshall,et al.  Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.

[19]  P. Enkhbaatar,et al.  The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants , 2013, Shock.

[20]  Ivana V. Yang,et al.  Role of Macrophage Receptor with Collagenous Structure in Innate Immune Tolerance , 2013, The Journal of Immunology.

[21]  C. O. Kim,et al.  Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis , 2013, Critical Care.

[22]  Yihai Cao Erythropoietin in cancer: a dilemma in risk therapy , 2013, Trends in Endocrinology & Metabolism.

[23]  J. D. de Fijter,et al.  Randomized Trial of Short‐Course High‐Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  T. Standiford,et al.  Cathelicidin-Related Antimicrobial Peptide Is Required for Effective Lung Mucosal Immunity in Gram-Negative Bacterial Pneumonia , 2012, The Journal of Immunology.

[25]  R. Choi,et al.  Salidroside stimulates the accumulation of HIF-1α protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells. , 2012, European journal of pharmacology.

[26]  H. Tilg,et al.  Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways , 2011, Immunity.

[27]  Max Gassmann,et al.  Macrophages as novel target cells for erythropoietin , 2010, Haematologica.

[28]  J. D. Young,et al.  Bench to bedside: A role for erythropoietin in sepsis , 2010, Critical care.

[29]  T. Rogers,et al.  Major Differences Exist in Frequencies of Virulence Factors and Multidrug Resistance between Community and Nosocomial Escherichia coli Bloodstream Isolates , 2010, Journal of Clinical Microbiology.

[30]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[31]  D. Iliopoulos,et al.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.

[32]  Juan Zhang,et al.  Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. , 2009, European journal of pharmacology.

[33]  R. Kingston,et al.  WDR5 Interacts with Mixed Lineage Leukemia (MLL) Protein via the Histone H3-binding Pocket* , 2008, Journal of Biological Chemistry.

[34]  Xian-feng Chen,et al.  Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. , 2008, The Journal of surgical research.

[35]  G. Piraino,et al.  Peroxisome proliferator activated receptor γ is not necessary for the development of LPS‐induced tolerance in macrophages , 2008, Immunology.

[36]  J. Luyendyk,et al.  Genetic Analysis of the Role of the PI3K-Akt Pathway in Lipopolysaccharide-Induced Cytokine and Tissue Factor Gene Expression in Monocytes/Macrophages1 , 2008, The Journal of Immunology.

[37]  Ji Zhang,et al.  EPOR signaling: 450 million years' history , 2007 .

[38]  E. Sherwood,et al.  ENDOTOXIN PRETREATMENT IMPROVES BACTERIAL CLEARANCE AND DECREASES MORTALITY IN MICE CHALLENGED WITH STAPHYLOCOCCUS AUREUS , 2007, Shock.

[39]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.

[40]  A. Sytkowski Does Erythropoietin Have a Dark Side? Epo Signaling and Cancer Cells , 2007, Science's STKE.

[41]  Jun Asai,et al.  Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. , 2007, The American journal of pathology.

[42]  E. Sherwood,et al.  IMPROVED BACTERIAL CLEARANCE AND DECREASED MORTALITY CAN BE INDUCED BY LPS TOLERANCE AND IS NOT DEPENDENT UPON IFN-&ggr; , 2007, Shock.

[43]  J. Myklebust,et al.  PI3K/Akt‐dependent Epo‐induced signalling and target genes in human early erythroid progenitor cells , 2006, British journal of haematology.

[44]  Seppo Yla-Herttuala,et al.  Vascular endothelial growth factor-C accelerates diabetic wound healing. , 2006, The American journal of pathology.

[45]  B. Zingarelli,et al.  THE PHOSPHATIDYLINOSITOL 3 KINASE PATHWAY REGULATES TOLERANCE TO LIPOPOLYSACCHARIDE AND PRIMING RESPONSES TO STAPHYLOCOCCUS AUREUS AND LIPOPOLYSACCHARIDE , 2006, Shock.

[46]  S. Isenmann,et al.  Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation , 2005, Molecular and Cellular Neuroscience.

[47]  K. Maiese,et al.  New avenues of exploration for erythropoietin. , 2005, JAMA.

[48]  J. Kimpen,et al.  PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEVERE SEPSIS , 2005, Shock.

[49]  N. Mackman,et al.  PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[50]  S. Koyasu,et al.  PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.

[51]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[52]  C. Grimm,et al.  HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration , 2002, Nature Medicine.

[53]  N. Van Rooijen,et al.  Improved Innate Immunity of Endotoxin-Tolerant Mice Increases Resistance to Salmonella enterica Serovar Typhimurium Infection despite Attenuated Cytokine Response , 2001, Infection and Immunity.

[54]  David Brink,et al.  : A Review of the , 2018 .

[55]  F. Venet,et al.  Monitoring Immune Dysfunctions in the Septic Patient: A New Skin for the Old Ceremony , 2008, Molecular medicine.

[56]  M. Tomic-Canic,et al.  The Role of Vascular Endothelial Growth Factor in Wound Healing , 2022 .